Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Nexgel, Inc. Announces Termination of CEO Adam R. Levy
PUBLIC · NXGLAug 21, 2026•about 5 hours ago
Position
Chief Executive Officer
Company
NEXGEL
Adam R. Levy
LanghorneBiotechnologyHealth Care
Description
On August 21, 2026, NEXGEL, INC. terminated Adam R. Levy's employment as Chief Executive Officer without cause
Company Information
Company
NEXGEL
Location
2150 CABOT BOULEVARD WEST
Langhorne, Pennsylvania, United States
About
Nexgel is a company focused on developing and commercializing innovative hydrogel products. They specialize in regenerative biomaterials and have a range of products in various stages of development. The company aims to enhance patient care with their advanced biomaterial solutions. Nexgel is publicly traded under the ticker symbol NXGL.
Don't miss NEXGEL's next move
Get an email the moment NEXGEL changes its leadership, hires an exec, or expands, usually minutes after it happens.